newsfilter
← Latest News
GlobeNewswire·

MusclePharm Announces Third Quarter 2021 Financial Results

Company Continues Focus on Controlling Operating Expenses with 21% Decline in Third Quarter 2021 First Production Run of MP Combat Energy Successfully Sold 100%; $30 Million of Annual Sales Expected in 2023 Company Expects Sequential Revenu